home / stock / biib / biib short
Short Information | Biogen Inc. (NASDAQ:BIIB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,615,235 |
Total Actual Volume | 21,531,941 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 180,762 |
Average Short Percentage | 17.93% |
Is there a BIIB Short Squeeze or Breakout about to happen?
See the BIIB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $231.71 | $228.82 | $233.17 | $225.1 | 860,173 | 251,697 | 29.26% |
07-01-2024 | $231.41 | $231.77 | $236.81 | $230.645 | 862,657 | 171,952 | 19.93% |
06-28-2024 | $229.5 | $231.82 | $235.49 | $227.73 | 2,242,754 | 433,627 | 19.33% |
06-27-2024 | $223.43 | $228.72 | $230.12 | $222.79 | 1,005,470 | 233,106 | 23.18% |
06-26-2024 | $221.79 | $224.46 | $225.11 | $220.02 | 861,260 | 144,294 | 16.75% |
06-25-2024 | $225.48 | $223.19 | $229.53 | $222.83 | 812,590 | 156,325 | 19.24% |
06-24-2024 | $225.74 | $226.6 | $227.79 | $223.63 | 1,000,260 | 115,981 | 11.6% |
06-21-2024 | $227.35 | $224 | $228.15 | $222.05 | 3,013,444 | 156,991 | 5.21% |
06-20-2024 | $220.94 | $225.58 | $226.33 | $220.375 | 676,237 | 121,655 | 17.99% |
06-18-2024 | $226.59 | $223.65 | $228.5 | $223.02 | 757,238 | 105,962 | 13.99% |
06-17-2024 | $230.83 | $226.46 | $230.83 | $225.615 | 993,734 | 133,174 | 13.4% |
06-14-2024 | $232.56 | $231.69 | $233.71 | $230.255 | 747,882 | 110,990 | 14.84% |
06-13-2024 | $227.72 | $233.84 | $234.385 | $227.06 | 994,336 | 214,886 | 21.61% |
06-12-2024 | $227.62 | $230.63 | $232.34 | $226.5329 | 1,036,684 | 188,274 | 18.16% |
06-11-2024 | $225.73 | $225.74 | $228.53 | $225.31 | 937,365 | 159,993 | 17.07% |
06-10-2024 | $224.52 | $225.98 | $229 | $224.25 | 919,214 | 183,178 | 19.93% |
06-07-2024 | $230.61 | $225.43 | $230.96 | $224.66 | 958,650 | 155,836 | 16.26% |
06-06-2024 | $235.1 | $231.99 | $236.71 | $230.01 | 887,370 | 180,649 | 20.36% |
06-05-2024 | $234.45 | $236.72 | $237.54 | $230.3908 | 947,930 | 192,230 | 20.28% |
06-04-2024 | $229.82 | $234.13 | $234.39 | $228.83 | 1,016,693 | 204,435 | 20.11% |
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases ...
TOKYO and CAMBRIDGE, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today tha...
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting ...